Objective: To evaluate the efficacy and feasibility of ultrasound-guided percutaneous thermal ablation (TA) for treating benign parotid tumors.Methods: Patients with benign parotid tumors who underwent ultrasound-guided microwave ablation (MWA) or radiofrequency ablation (RFA) between January 2020 and March 2023 were included in this retrospective study. Change in tumor size (maximum diameter, tumor volume(V), volume reduction rate (VRR)) and cosmetic score (CS) were evaluated during a one-year follow-up period. We also recorded the incidence of any complications associated with TA.Results: A total of 23 patients (13 males and 10 females; median age 65 years, range 5-91 years) were included. The mean VRR at 1, 3, 6, and 12 months after TA was 37.03%+/- 10.23%, 56.52%+/- 8.76%, 82.28%+/- 7.89%, and 89.39%+/- 6.45%, respectively. Mean CS also changed from 3.39 +/- 0.66 to 1.75 +/- 0.93 (p < 0.001) by the end of follow-up time. Subgroup analysis showed that tumors with smaller initial maximum diameter had a faster CS reduction rate than those with larger initial diameter. The incidence of facial nerve dysfunction was 8.70%.Conclusion: Ultrasound-guided percutaneous TA is an effective and safe treatment option for patients with benign parotid tumors.
基金：
National Key R&D Program of China
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|3 区医学
小类|3 区肿瘤学3 区核医学
最新[2023]版：
大类|3 区医学
小类|3 区肿瘤学3 区核医学
JCR分区：
出版当年[2023]版：
Q2ONCOLOGYQ2RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2023]版：
Q2ONCOLOGYQ2RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
第一作者机构：[1]Univ Elect Sci & Technol China, Sichuan Clin Res Ctr Canc, Sichuan Canc Ctr, Sichuan Canc Hosp & Inst,Affiliated Canc Hosp,Ultr, Chengdu, Peoples R China
共同第一作者：
通讯作者：
通讯机构：[1]Univ Elect Sci & Technol China, Sichuan Clin Res Ctr Canc, Sichuan Canc Ctr, Sichuan Canc Hosp & Inst,Affiliated Canc Hosp,Ultr, Chengdu, Peoples R China[3]Fujian Med Univ, Fujian Prov Hosp, Shengli Clin Med Coll, Dept Ultrasonog, Fuzhou, Peoples R China[*1]Ultrasonography Department, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China[*2]Department of Ultrasonography, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China
推荐引用方式(GB/T 7714)：
Zhuang Min,Lin Yucheng,Wu Songsong,et al.Ultrasound-guided percutaneous thermal ablation of parotid tumors: experience from two-centers[J].INTERNATIONAL JOURNAL OF HYPERTHERMIA.2024,41(1):doi:10.1080/02656736.2023.2290924.
APA：
Zhuang, Min,Lin, Yucheng,Wu, Songsong,Lu, Man,Jiang, Zirui...&He, Yi.(2024).Ultrasound-guided percutaneous thermal ablation of parotid tumors: experience from two-centers.INTERNATIONAL JOURNAL OF HYPERTHERMIA,41,(1)
MLA：
Zhuang, Min,et al."Ultrasound-guided percutaneous thermal ablation of parotid tumors: experience from two-centers".INTERNATIONAL JOURNAL OF HYPERTHERMIA 41..1(2024)
